Clinically relevant fatigue in recurrence-free prostate cancer survivors

Annals of Oncology

Volumn 23, Issue 1, 2012, Pages 65-72

  Storey, D J ^a,b   Mclaren, D B ^b   Atkinson, M A ^b   Butcher, I ^a   Liggatt, S ^b   O'dea, R ^b   Smyth, J F ^a   Sharpe, M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

Cancer; Fatigue; Prostate; Radiotherapy; Surgery; Survivor

Indexed keywords

AGED; ANXIETY DISORDER; ARTICLE; CANCER FATIGUE; CANCER PAIN; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVOR; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE CONTROL; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; QUESTIONNAIRE; RECURRENCE FREE SURVIVAL; SCORING SYSTEM; SURVIVAL TIME; URINARY TRACT DISEASE;

EID: 84855168530     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdr034     Document Type: Article

References (42)

1. SEER. Cancer Statistics Review http://seer.cancer.gov/csr/1975_2005/index.html (12 October 2010, date last accessed).
2. Cancer Research UK. UK Cancer Incidence Statistics for Common Cancers http://info.cancerresearchuk.org/cancerstats/incidence/commoncancers/(12 October 2010, date last accessed).
3. Potosky AL, Davis WW, Hoffman RM et al. Five-year outcomes after prostatectomy or radiotherapy for prostate cancer: the prostate cancer outcomes study. J Natl Cancer Inst 2004; 96(18): 1358-1367.
4. Potosky AL, Legler J, Albertsen PC et al. Health outcomes after prostatectomy or radiotherapy for prostate cancer: results from the Prostate Cancer Outcomes Study. J Natl Cancer Inst 2000; 92(19): 1582-1592.
5. Bacon CG, Giovannucci E, Testa M, Kawachi I. The impact of cancer treatment on quality of life outcomes for patients with localized prostate cancer. J Urol 2001; 166(5): 1804-1810.
6. Lilleby W, Fossa SD, Waehre HR, Olsen DR. Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int J Radiat Oncol Biol Phys 1999; 43: 735-743.
7. Stone P, Richardson A, Ream E et al. Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer Fatigue Forum. Ann Oncol 2000; 11: 971-975.
8. Fossa SD, Dahl AA, Loge JH. Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol 2003; 21: 1249-1254.
9. Bower JE, Ganz PA, Desmond KA et al. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 2000; 18: 743-753.
10. Hjermstad MJ, Oldervoll L, Fossa SD et al. Quality of life in long-term Hodgkin's disease survivors with chronic fatigue. Eur J Cancer 2006; 42: 327-333.
11. Monga U, Kerrigan AJ, Thornby J, Monga TN. Prospective study of fatigue in localized prostate cancer patients undergoing radiotherapy. Radiat Oncol Investig 1999; 7: 178-185.
12. Greenberg DB, Gray JL, Mannix CM et al. Treatment-related fatigue and serum interleukin-1 levels in patients during external beam irradiation for prostate cancer. J Pain Symptom Manage 1993; 8: 196-200.
13. Geinitz H, Zimmermann F, Thamm R et al. Fatigue, quality of life and treatmentrelated toxicity during conformal radiation therapy (CRT) of patients with prostate cancer. Int J Radiat Oncol Biol Phys 2003; 57: S441-S442.
14. Windsor PM, Nicol KF, Potter J. A randomized, controlled trial of aerobic exercise for treatment-related fatigue in men receiving radical external beam radiotherapy for localized prostate carcinoma. Cancer 2004; 101: 550-557.
15. Rodrigues G, Bezjak A, Osoba D et al. The relationship of changes in EORTC QLQ-C30 scores to ratings on the Subjective Significance Questionnaire in men with localized prostate cancer. Qual Life Res 2004; 13(7): 1235-1246.
16. Geinitz H, Thamm R, Scholz C et al. Longitudinal analysis of quality of life in patients receiving conformal radiation therapy for prostate cancer. Strahlenther Onkol 2010; 186: 46-52.
17. Vordermark D, Schwab M, Flentje M et al. Chronic fatigue after radiotherapy for carcinoma of the prostate: correlation with anorectal and genitourinary function. Radiother Oncol 2002; 62: 293-297.
18. Hervouet S, Savard J, Simard S et al. Psychological functioning associated with prostate cancer: cross-sectional comparison of patients treated with radiotherapy, brachytherapy, or surgery. J Pain Symptom Manage 2005; 30: 474-484.
19. Kyrdalen AE, Dahl AA, Hernes E et al. Fatigue in hormone-naive prostate cancer patients treated with radical prostatectomy or definitive radiotherapy. Prostate Cancer Prostatic Dis 2010; 13: 144-150.
20. SIMD. Scottish Index of Multiple Deprivation 2004; http://www.scotland.gov.uk/Publications/2004/06/19421/38085 (12 October 2010, date last accessed).
21. Mendoza TR, Wang XS, Cleeland CS et al. The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory. Cancer 1999; 85: 1186-1196.
22. NCCN. Clinical Practice Guidelines in Oncology: Cancer Related Fatigue v. 1. 2009; http://www.nccn.org/professionals/physician_gls/PDF/fatigue.pdf. In Edition 2009 (12 October 2010, date last accessed).
23. Shafqat A, Einhorn LH, Hanna N et al. Screening studies for fatigue and laboratory correlates in cancer patients undergoing treatment. Ann Oncol 2005; 16: 1545-1550.
24. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67(6): 361-370.
25. Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res 2002; 52: 69-77.
26. Fossa SD, Woehre H, Kurth KH et al. Influence of urological morbidity on quality of life in patients with prostate cancer. Eur Urol 1997; 31 (Suppl 3): 3-8.
27. Aaronson NK, Ahmedzai S, Bergman B et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85(5): 365-376.
28. Fayers P, Aaronson N, Bjordal K et al. EORTC QLQ-C30 Scoring Manual. Brussels, Belgium: EORTC 2001.
29. Stone P, Hardy J, Huddart R et al. Fatigue in patients with prostate cancer receiving hormone therapy. Eur J Cancer 2000; 36: 1134-1141.
30. Jakobsson L, Loven L, Hallberg IR. Micturition problems in relation to quality of life in men with prostate cancer or benign prostatic hyperplasia: comparison with men from the general population. Cancer Nurs 2004; 27(3): 218-229.
31. Nejat RJ, Rashid HH, Bagiella E et al. A prospective analysis of time to normalization of serum testosterone after withdrawal of androgen deprivation therapy. J Urol 2000; 164: 1891-1894.
32. Storey DJ, Waters RA, Hibberd CJ et al. Clinically relevant fatigue in cancer outpatients: the Edinburgh Cancer Centre symptom study. Ann Oncol 2007; 18(11): 1861-1869.
33. Aktas A, Walsh D, Rybicki L. Symptom clusters: myth or reality? Palliat Med 2010; 24: 373-385.
34. Cella D, Peterman A, Passik S et al. Progress toward guidelines for the management of fatigue. Oncology 1998; 12: 369-377.
35. Osoba D, Rodrigues G, Myles J et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 1998; 16(1): 139-144.
36. Maliski SL, Kwan L, Orecklin JR et al. Predictors of fatigue after treatment for prostate cancer. Urology 2005; 65: 101-108.
37. Fransson P, Damber J-E, Widmark A. Health-related quality of life 10 years after external beam radiotherapy or watchful waiting in patients with localized prostate cancer. Scand J Urol Nephrol 2009; 43: 119-126.
38. Brandeis JM, Litwin MS, Burnison CM, Reiter RE. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 2000; 163(3): 851-857.
39. Penson DF, Feng Z, Kuniyuki A et al. General quality of life 2 years following treatment for prostate cancer: what influences outcomes? Results from the prostate cancer outcomes study. J Clin Oncol 2003; 21: 1147-1154.
40. Geinitz H, Zimmermann FB, Thamm R et al. Late rectal symptoms and quality of life after conformal radiation therapy for prostate cancer. Radiother Oncol 2006; 79: 341-347.
41. Kim SH, Son BH, Hwang SY et al. Fatigue and depression in disease-free breast cancer survivors: prevalence, correlates, and association with quality of life. J Pain Symptom Manage 2008; 35: 644-655.
42. Altman DG, Royston P. The cost of dichotomising continuous variables. BMJ 2006; 332(7549): 1080.